关注
Noemie Jourde-Chiche
Noemie Jourde-Chiche
Aix-Marseille University, Department of Nephrology, Vascular Research Center of Marseille
在 ap-hm.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ...
The Lancet Infectious Diseases 17 (5), 510-519, 2017
5082017
The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells
L Dou, N JOURDE‐CHICHE, V Faure, C Cerini, Y Berland, ...
Journal of Thrombosis and Haemostasis 5 (6), 1302-1308, 2007
4572007
Endothelium structure and function in kidney health and disease
N Jourde-Chiche, F Fakhouri, L Dou, J Bellien, S Burtey, M Frimat, ...
Nature Reviews Nephrology 15 (2), 87-108, 2019
4042019
Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures
L Chiche, N Jourde‐Chiche, E Whalen, S Presnell, V Gersuk, K Dang, ...
Arthritis & rheumatology 66 (6), 1583-1595, 2014
3792014
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled …
P Charles, B Terrier, É Perrodeau, P Cohen, S Faguer, A Huart, ...
Annals of the rheumatic diseases 77 (8), 1143-1149, 2018
3152018
The cardiovascular effect of the uremic solute indole-3 acetic acid
L Dou, M Sallée, C Cerini, S Poitevin, B Gondouin, N Jourde-Chiche, ...
Journal of the American society of nephrology 26 (4), 876-887, 2015
3042015
Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway
B Gondouin, C Cerini, L Dou, M Sallée, A Duval-Sabatier, A Pletinck, ...
Kidney international 84 (4), 733-744, 2013
2402013
Acute renal infarction: a case series
M Bourgault, P Grimbert, C Verret, J Pourrat, M Herody, JM Halimi, ...
Clinical Journal of the American Society of Nephrology 8 (3), 392-398, 2013
2212013
Mortality associated with systemic lupus erythematosus in France assessed by multiple‐cause‐of‐death analysis
G Thomas, J Mancini, N Jourde‐Chiche, G Sarlon, Z Amoura, JR Harlé, ...
Arthritis & rheumatology 66 (9), 2503-2511, 2014
2162014
Vascular incompetence in dialysis patients—protein‐bound uremic toxins and endothelial dysfunction
N Jourde‐Chiche, L Dou, C Cerini, F Dignat‐George, P Brunet
Seminars in dialysis 24 (3), 327-337, 2011
2022011
Progress in uremic toxin research: protein‐bound toxins—update 2009
N Jourde‐Chiche, L Dou, C Cerini, F Dignat‐George, R Vanholder, ...
Seminars in dialysis 22 (4), 334-339, 2009
1982009
Does uremia cause vascular dysfunction
P Brunet, B Gondouin, A Duval-Sabatier, L Dou, C Cerini, ...
Kidney and blood pressure research 34 (4), 284-290, 2011
1862011
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty‐seven patients
M Jachiet, B Flageul, A Deroux, A Le Quellec, F Maurier, F Cordoliani, ...
Arthritis & rheumatology 67 (2), 527-534, 2015
1672015
Characteristics and management of IgA vasculitis (Henoch‐Schönlein) in adults: data From 260 patients included in a french multicenter retrospective survey
A Audemard‐Verger, B Terrier, A Dechartres, J Chanal, Z Amoura, ...
Arthritis & rheumatology 69 (9), 1862-1870, 2017
1482017
Circulating endothelial cells as a marker of endothelial injury in severe COVID-19
C Guervilly, S Burtey, F Sabatier, R Cauchois, G Lano, E Abdili, F Daviet, ...
The Journal of infectious diseases 222 (11), 1789-1793, 2020
1322020
Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients
N JOURDE‐CHICHE, L Dou, F Sabatier, R Calaf, C Cerini, S Robert, ...
Journal of Thrombosis and Haemostasis 7 (9), 1576-1584, 2009
1302009
Clinical and genetic spectrum of Bartter syndrome type 3
E Seys, O Andrini, M Keck, L Mansour-Hendili, PY Courand, C Simian, ...
Journal of the American Society of Nephrology 28 (8), 2540-2552, 2017
1272017
Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome
J Zuber, M Frimat, S Caillard, N Kamar, P Gatault, F Petitprez, L Couzi, ...
Journal of the American Society of Nephrology 30 (12), 2449-2463, 2019
1062019
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors
A Le Clech, N Simon-Tillaux, F Provôt, Y Delmas, P Vieira-Martins, ...
Kidney international 95 (6), 1443-1452, 2019
1042019
Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease
L Dou, S Poitevin, M Sallée, T Addi, B Gondouin, N McKay, MS Denison, ...
Kidney international 93 (4), 986-999, 2018
1042018
系统目前无法执行此操作,请稍后再试。
文章 1–20